ECM
PFE icon

EagleClaw Capital Management’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$640K Sell
26,418
-863
-3% -$20.9K 0.1% 100
2025
Q1
$691K Buy
27,281
+100
+0.4% +$2.53K 0.11% 98
2024
Q4
$721K Sell
27,181
-463
-2% -$12.3K 0.11% 96
2024
Q3
$800K Sell
27,644
-750
-3% -$21.7K 0.13% 93
2024
Q2
$794K Hold
28,394
0.14% 92
2024
Q1
$788K Buy
28,394
+1,000
+4% +$27.8K 0.14% 92
2023
Q4
$789K Hold
27,394
0.16% 89
2023
Q3
$909K Hold
27,394
0.21% 83
2023
Q2
$1M Sell
27,394
-2,015
-7% -$73.9K 0.23% 80
2023
Q1
$1.2M Hold
29,409
0.28% 76
2022
Q4
$1.51M Hold
29,409
0.36% 72
2022
Q3
$1.29M Buy
29,409
+1,401
+5% +$61.3K 0.36% 70
2022
Q2
$1.47M Sell
28,008
-1,726
-6% -$90.5K 0.4% 67
2022
Q1
$1.54M Sell
29,734
-825
-3% -$42.7K 0.35% 68
2021
Q4
$1.81M Buy
30,559
+600
+2% +$35.4K 0.4% 63
2021
Q3
$1.29M Buy
29,959
+625
+2% +$26.8K 0.33% 69
2021
Q2
$1.15M Hold
29,334
0.3% 71
2021
Q1
$1.06M Buy
29,334
+950
+3% +$34.4K 0.31% 71
2020
Q4
$1.05M Sell
28,384
-5,200
-15% -$191K 0.33% 68
2020
Q3
$1.23M Buy
33,584
+6,415
+24% +$236K 0.43% 62
2020
Q2
$888K Sell
27,169
-15,804
-37% -$517K 0.34% 67
2020
Q1
$1.4M Buy
42,973
+900
+2% +$29.4K 0.66% 49
2019
Q4
$1.65M Buy
42,073
+13,993
+50% +$549K 0.6% 56
2019
Q3
$1.01M Buy
28,080
+12,876
+85% +$463K 0.41% 67
2019
Q2
$657K Sell
15,204
-137
-0.9% -$5.92K 0.29% 79
2019
Q1
$649K Hold
15,341
0.3% 81
2018
Q4
$670K Buy
15,341
+300
+2% +$13.1K 0.35% 71
2018
Q3
$662K Buy
15,041
+7,374
+96% +$325K 0.29% 75
2018
Q2
$278K Buy
7,667
+125
+2% +$4.53K 0.13% 100
2018
Q1
$268K Hold
7,542
0.14% 100
2017
Q4
$273K Buy
+7,542
New +$273K 0.14% 100